Ερευνητικό υλικό ΕΚΠΑ

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Αγγλικά

Background: Mobile technology may help to better understand the adherence to treatment. MASK-rhinitis (Mobile Airways Sentinel NetworK for allergic rhinitis) is a patient-centred ICT system. A mobile phone app (the Allergy Diary) central to MASK is available in 22 countries. Objectives: To assess the adherence to treatment in allergic rhinitis patients using the Allergy Diary App. Methods: An observational cross-sectional study was carried out on all users who filled in the Allergy Diary from 1 January 2016 to 1 August 2017. Secondary adherence was assessed by using the modified Medication Possession Ratio (MPR) and the Proportion of days covered (PDC) approach. Results: A total of 12 143 users were registered. A total of 6 949 users reported at least one VAS data recording. Among them, 1 887 users reported ≥7 VAS data. About 1 195 subjects were included in the analysis of adherence. One hundred and thirty-six (11.28%) users were adherent (MPR ≥70% and PDC ≤1.25), 51 (4.23%) were partly adherent (MPR ≥70% and PDC = 1.50) and 176 (14.60%) were switchers. On the other hand, 832 (69.05%) users were non-adherent to medications (MPR <70%). Of those, the largest group was non-adherent to medications and the time interval was increased in 442 (36.68%) users. Conclusion and clinical relevance: Adherence to treatment is low. The relative efficacy of continuous vs on-demand treatment for allergic rhinitis symptoms is still a matter of debate. This study shows an approach for measuring retrospective adherence based on a mobile app. This also represents a novel approach for analysing medication-taking behaviour in a real-world setting. © 2018 John Wiley & Sons Ltd

2019

Menditto, E.
Costa, E.
Midão, L.
Bosnic-Anticevich, S.
Novellino, E.
Bialek, S.
Briedis, V.
Mair, A.
Rajabian-Soderlund, R.
Arnavielhe, S.
Bedbrook, A.
Czarlewski, W.
Annesi-Maesano, I.
Anto, J.M.
Devillier, P.
De Vries, G.
Keil, T.
Sheikh, A.
Orlando, V.
Larenas-Linnemann, D.
Cecchi, L.
De Feo, G.
Illario, M.
Stellato, C.
Fonseca, J.
Malva, J.
Morais-Almeida, M.
Pereira, A.M.
Todo-Bom, A.M.
Kvedariene, V.
Valiulis, A.
Bergmann, K.C.
Klimek, L.
Mösges, R.
Pfaar, O.
Zuberbier, T.
Cardona, V.
Mullol, J.
Papadopoulos, N.G.
Prokopakis, E.P.
Bewick, M.
Ryan, D.
Roller-Wirnsberger, R.E.
Tomazic, P.V.
Cruz, A.A.
Kuna, P.
Samolinski, B.
Fokkens, W.J.
Reitsma, S.
Bosse, I.
Fontaine, J.-F.
Laune, D.
Haahtela, T.
Toppila-Salmi, S.
Bachert, C.
Hellings, P.W.
Melén, E.
Wickman, M.
Bindslev-Jensen, C.
Eller, E.
O'Hehir, R.E.
Cingi, C.
Gemicioğlu, B.
Kalayci, O.
Ivancevich, J.C.
Bousquet, J.
the MASK group

Clinical and Experimental Allergy

Wiley-Blackwell Publishing Ltd

adult; aged; allergic rhinitis; cell phone use; clinical trial; cross-sectional study; female; human; male; medical record; medication compliance; middle aged; mobile application; multicenter study; outcome assessment; questionnaire, Adult; Aged; Cell Phone Use; Cross-Sectional Studies; Female; Humans; Male; Medical Records; Medication Adherence; Middle Aged; Mobile Applications; Patient Outcome Assessment; Rhinitis, Allergic; Surveys and Questionnaires

https://doi.org/10.1111/cea.13333

10.1111/cea.13333

https://pergamos.lib.uoa.gr/uoa/dl/object/3000566